Skip to main content
Polaris AI Pharma Corp. logo

Polaris AI Pharma Corp. — Investor Relations & Filings

Ticker · 041910 ISIN · KR7041910001 KO Manufacturing
Open in API
Filings indexed 164 across all filing types
Latest filing 2025-03-12 Audit Report / Informat…
Country KR South Korea
Listing KO 041910

About Polaris AI Pharma Corp.

https://polarisaipharma.com/

Polaris AI Pharma Corp., formerly known as ESTECHPHARMA CO., LTD, is a company engaged in the development, manufacture, and supply of active pharmaceutical ingredients (APIs) and fine chemicals. The company specializes in producing raw materials for generic drugs across various therapeutic categories. Its product portfolio includes APIs for treatments such as anti-thrombosis, anti-ulcer, asthma, and alcohol dependence.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from Polaris AI Pharma. It provides the audit opinion (unqualified/proper), key financial data, and confirms the receipt of the audit report. While it contains financial data, it is a standard regulatory disclosure announcement regarding the filing of the audit report rather than the full annual report (10-K) or a standalone audit report document. Following the 'Menu vs Meal' rule, this is a notification of the report's submission to the regulatory body. FY 2024
2025-03-12 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Polaris AI Pharma) disclosing a significant change in financial results (revenue or profit structure change of 30% or more). This is a standard regulatory disclosure requirement in the Korean market (DART system) for preliminary earnings results before the final audit report is finalized. Since it provides specific financial highlights and performance metrics rather than just an announcement of a report's availability, it falls under the 'Earnings Release' category. FY 2024
2025-03-05 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Polaris AI Pharma. It outlines the date, location, and agenda items (such as approval of financial statements and director compensation). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2025-03-05 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a '주주총회소집공고' (Notice of Convocation of General Meeting of Shareholders) for Polaris AI Pharma. It contains the meeting agenda, date, location, and detailed management information including board activities, major shareholder transactions, and financial statements (balance sheet and income statement) for the 26th fiscal year. This document is a standard proxy statement/notice sent to shareholders to inform them of the upcoming meeting and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2025-03-05 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of determining shareholders eligible to vote at an upcoming Annual General Meeting (AGM). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of the record date. Given the nature of the announcement as a regulatory disclosure regarding shareholder rights for a meeting, it fits best under the RNS (Regulatory Filings) category as it is a standard corporate disclosure that does not fall into the specific categories of proxy solicitation or full AGM materials.
2024-12-16 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Polaris AI Pharma' covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.